Jay Zaveri
Partner | Head, Early Stage & Venture @ Social Capital
San Francisco Bay Area, United States
Jay Zaveri is a seed investor at Social Capital in San Francisco Bay Area focused on Health Care and Biotechnology. Jay Zaveri is based out of Menlo Park, California, and is the President and Board of Directors of Aether Bio and Founder and Partner of Natural Capital.
- Total investments:
- 72
- Last investment:
- Lead investor:
- 26%
Last updated:
For AI agents: llms.txt
Industries Jay Zaveri invests in
Stages Jay Zaveri invests in
Countries Jay Zaveri invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1M–$4M
- Series A
- $3M–$25M
- Series B
- $25M–$6B
Investment Focus
Industry
- Health Care 10 (14%)
- Biotechnology 10 (14%)
- Artificial Intelligence 10 (14%)
- Software 7 (10%)
- Medical 5 (7%)
Stage
- Seed 26 (36%)
- Series A 13 (18%)
- Series B 8 (11%)
- Venture - Series Unknown 7 (10%)
- Funding Round 5 (7%)
Country
- United States 42 (58%)
- Japan 1 (1%)
- Canada 1 (1%)
- Latvia 1 (1%)
- Nigeria 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Odyssey operates as an AI start-up, provides hollywood-grade visual AI. | $310M / Series B / Jun 17, 2026 | ||
| Xona Space Systems is building a next-generation satellite navigation system using small but powerful satellites in low-Earth orbit. The constellation they are developing is designed to provide secure navigation and timing services with the resilience and accuracy that modern intelligent systems, such as autonomous vehicles and drones, need tooperate safely at scale. | $170M / Series C / Mar 26, 2026 | ||
| Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to getthe chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition. | $15M / Venture - Series Unknown / Dec 03, 2025 | ||
| ZeroBrush develops an automated toothbrush designed with a custom-fit mouthpiece created from a 3D model of the user’s teeth. The product is engineered to clean all teeth simultaneously, aiming to improve coverage compared to traditional brushing methods. Its design targets hard-to-reach surfaces and works to reduce plaque buildup within a shortercleaning cycle. ZeroBrush incorporates technology intended to replicate a consistent level of cleaning for each tooth. The company focuses on oral care innovation through combining personalized dental fitting with automated brushing functionality. | $10.8M / Series A / Sep 09, 2025 | ||
| XAI is an AI company that develops a platform to accelerate human scientific discovery. The company primarily focuses on developing advanced AI systems that are truthful, competent, and maximally beneficial for all of humanity. Its mission is to understand the true nature of the universe. | $5.3B / Venture - Series Unknown / Jul 13, 2025 | ||
| Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology. | $50M / Series B / Jan 13, 2025 | ||
| XAI is an AI company that develops a platform to accelerate human scientific discovery. The company primarily focuses on developing advanced AI systems that are truthful, competent, and maximally beneficial for all of humanity. Its mission is to understand the true nature of the universe. | $6B / Series B / May 26, 2024 | ||
| Tierra Biosciences is an operator of a synthetic biology company intended to accelerate the pace of discovery to enable the next generation of bioengineered products. The company's protein platform leverages cell-free protein production and artificial intelligence and couples high-throughput protein manufacturing with the simplicity ofe-commerce. | $11.4M / Series A / Mar 12, 2024 | ||
| Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to getthe chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition. | $49M / Series A / Aug 16, 2023 | ||
| Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs, manufactures, and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusablelaunch vehicles Falcon 1 and Falcon 9.Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California. | $750M / Private Equity / Jan 02, 2023 | ||
| See all 72 investments → | |||
Co-Investors
About Social Capital
Social Capital is a Menlo Park-based investment firm whose mission is to advance humanity by solving the world’s hardest problems. By harnessing technology to address core human needs, they aim to drive a bottom-up redistribution of power, capital and opportunity. To achieve this, they're building a new kind of company and a platform forempowering brilliant entrepreneurs and breakthrough products.Founded in 2011, the company is based in Menlo Park, California, United States.
Social Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chamath Palihapitiya
Founder and Chief Executive Officer
|
|||
Ray Ko
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Jay Zaveri invest in?
Jay Zaveri invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 72 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jay Zaveri's check size?
Jay Zaveri typically joins rounds of $1M–$4M at Seed, $3M–$25M at Series A and $25M–$6B at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jay Zaveri participates in.
How do I contact Jay Zaveri?
Public channels for Jay Zaveri include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jay Zaveri last invest?
The most recent investment recorded for Jay Zaveri closed in Jun 2026. Shizune tracks 72 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
